PTSD Trial, Recruiting NCT04770584 Sponsor: The University of Texas Health Science Center, Houston Condition: PTSD
Back to Ptsd

PTSD Trial, Recruiting

NCT04770584
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 to 70 years old, of any gender
  • People with a current diagnosis of PTSD (for the PTSD group)
  • People who have experienced trauma but have no current mental health (psychiatric) disorders and no current PTSD (for the trauma-exposed healthy control group)
  • People who have no history of trauma and no current mental health (psychiatric) disorders (for the healthy control group)
  • People who are willing and able to give informed consent to participate

Who may not be able to join:

  • People with a history of a neurological disease, such as a tic disorder
  • People with significant current thoughts of suicide or a history of suicidal behaviour in the past 6 months, or self-harming behaviour that is serious, frequent, or requires medical care
  • People with a history of seizures or a significant head injury
  • People with a history of a serious mental health (psychiatric) disorder
  • People who have used antipsychotic medications within the past year
  • People whose urine test shows current use of certain substances (note: a positive result for THC/cannabis may be reviewed by the lead researcher on a case-by-case basis — confirm with trial site)
  • People who are pregnant (confirmed by a urine test)
  • People who have metal implants or devices in their body that make MRI scans unsafe
  • People considered to be at high risk of a difficult emotional or behavioural reaction to the study, or who are unable to understand the study procedures or the consent process
  • People in the trauma-exposed healthy control group or healthy control group who have any current mental health (psychiatric) diagnosis

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mohammed Milad, PhD, The University of Texas Health Science Center at Houston (UTHealth Houston)

Phone: 713-486-2754

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
9 September 2021
Est. completion
1 January 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Skin Conductance Response (SCR); Functional MRI (fMRI) responses

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov